Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 14 | 2017 | 192 | 1.950 |
Why?
|
| Monocytes | 7 | 2021 | 126 | 1.760 |
Why?
|
| Cholesterol | 12 | 2020 | 251 | 1.740 |
Why?
|
| Inflammation | 9 | 2022 | 540 | 1.430 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2020 | 56 | 1.390 |
Why?
|
| ATP-Binding Cassette Transporters | 6 | 2013 | 60 | 1.300 |
Why?
|
| Energy Metabolism | 2 | 2020 | 148 | 1.240 |
Why?
|
| Signal Transduction | 7 | 2020 | 687 | 1.010 |
Why?
|
| Atherosclerosis | 9 | 2020 | 767 | 1.000 |
Why?
|
| Mice | 29 | 2022 | 2476 | 0.920 |
Why?
|
| Lipoproteins, HDL | 7 | 2015 | 251 | 0.870 |
Why?
|
| Membrane Microdomains | 5 | 2015 | 21 | 0.780 |
Why?
|
| Animals | 33 | 2022 | 7450 | 0.770 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 2022 | 18 | 0.750 |
Why?
|
| Succinates | 1 | 2020 | 6 | 0.710 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 11 | 0.700 |
Why?
|
| Liver | 7 | 2017 | 482 | 0.690 |
Why?
|
| Apolipoprotein A-I | 7 | 2015 | 68 | 0.670 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2017 | 29 | 0.620 |
Why?
|
| Toll-Like Receptors | 3 | 2015 | 23 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 13 | 2017 | 766 | 0.620 |
Why?
|
| Autophagy | 2 | 2017 | 52 | 0.610 |
Why?
|
| Dietary Fats | 2 | 2017 | 110 | 0.590 |
Why?
|
| Mice, Knockout | 12 | 2020 | 444 | 0.550 |
Why?
|
| Receptors, LDL | 9 | 2020 | 65 | 0.550 |
Why?
|
| Aging | 3 | 2020 | 941 | 0.540 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2010 | 16 | 0.540 |
Why?
|
| Lipopolysaccharides | 7 | 2020 | 109 | 0.530 |
Why?
|
| Myeloid Cells | 2 | 2014 | 39 | 0.530 |
Why?
|
| Insulin Resistance | 4 | 2017 | 461 | 0.470 |
Why?
|
| Apolipoproteins | 5 | 2015 | 200 | 0.430 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 9 | 0.430 |
Why?
|
| Hematopoiesis | 1 | 2012 | 33 | 0.410 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 104 | 0.390 |
Why?
|
| Hepatocytes | 3 | 2017 | 76 | 0.370 |
Why?
|
| Carnitine | 2 | 2020 | 14 | 0.340 |
Why?
|
| Mitochondria | 3 | 2022 | 186 | 0.340 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 68 | 0.340 |
Why?
|
| Metabolome | 2 | 2020 | 36 | 0.340 |
Why?
|
| Amino Acids | 2 | 2020 | 46 | 0.330 |
Why?
|
| Cytokines | 5 | 2020 | 259 | 0.330 |
Why?
|
| Obesity | 3 | 2013 | 1158 | 0.320 |
Why?
|
| Cysteine | 2 | 2008 | 138 | 0.300 |
Why?
|
| Apolipoproteins E | 4 | 2013 | 94 | 0.250 |
Why?
|
| Sphingosine | 2 | 2015 | 13 | 0.240 |
Why?
|
| Lysophospholipids | 2 | 2015 | 24 | 0.240 |
Why?
|
| Cells, Cultured | 5 | 2015 | 833 | 0.230 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1122 | 0.230 |
Why?
|
| Macrophages, Peritoneal | 2 | 2014 | 18 | 0.230 |
Why?
|
| Plant Oils | 2 | 2015 | 16 | 0.230 |
Why?
|
| Interleukin-1beta | 3 | 2020 | 43 | 0.230 |
Why?
|
| Sepsis | 2 | 2022 | 158 | 0.220 |
Why?
|
| Humans | 17 | 2022 | 31836 | 0.220 |
Why?
|
| Fatty Acids | 3 | 2020 | 97 | 0.220 |
Why?
|
| Chemokines | 2 | 2013 | 36 | 0.220 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 29 | 0.210 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 6 | 0.210 |
Why?
|
| Aortic Diseases | 2 | 2013 | 63 | 0.210 |
Why?
|
| Endothelium, Vascular | 3 | 2012 | 155 | 0.190 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 268 | 0.190 |
Why?
|
| Male | 12 | 2020 | 19091 | 0.190 |
Why?
|
| Enzyme Activation | 3 | 2017 | 135 | 0.190 |
Why?
|
| NF-kappa B | 3 | 2010 | 81 | 0.190 |
Why?
|
| Glycolysis | 1 | 2020 | 20 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 23 | 0.180 |
Why?
|
| Gene Deletion | 4 | 2017 | 66 | 0.180 |
Why?
|
| Lipids | 2 | 2020 | 228 | 0.180 |
Why?
|
| Diet, Atherogenic | 3 | 2015 | 61 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2021 | 189 | 0.180 |
Why?
|
| Ketones | 1 | 2020 | 11 | 0.180 |
Why?
|
| Caspase 1 | 2 | 2017 | 7 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1012 | 0.170 |
Why?
|
| NAD | 1 | 2019 | 27 | 0.170 |
Why?
|
| Transcription Factor RelB | 1 | 2019 | 26 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 38 | 0.170 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2009 | 14 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2019 | 71 | 0.170 |
Why?
|
| Nucleotides | 1 | 2019 | 16 | 0.170 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 15 | 0.170 |
Why?
|
| Aorta | 3 | 2015 | 125 | 0.160 |
Why?
|
| Antioxidants | 2 | 2010 | 114 | 0.150 |
Why?
|
| Lipogenesis | 1 | 2017 | 18 | 0.150 |
Why?
|
| Algorithms | 1 | 2020 | 495 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2010 | 40 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 261 | 0.130 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 105 | 0.130 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2015 | 8 | 0.130 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hypertension | 1 | 2022 | 956 | 0.130 |
Why?
|
| Spleen | 2 | 2013 | 86 | 0.130 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 36 | 0.130 |
Why?
|
| Protein Sorting Signals | 1 | 2015 | 6 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2015 | 45 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2015 | 96 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 61 | 0.120 |
Why?
|
| Female | 7 | 2020 | 19859 | 0.120 |
Why?
|
| Fatty Acid Desaturases | 1 | 2015 | 48 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 66 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 120 | 0.120 |
Why?
|
| Proteomics | 1 | 2015 | 94 | 0.120 |
Why?
|
| Fish Oils | 2 | 2015 | 36 | 0.120 |
Why?
|
| Lipocalins | 1 | 2013 | 6 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2015 | 245 | 0.120 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 6 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2013 | 23 | 0.110 |
Why?
|
| Epididymis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 159 | 0.110 |
Why?
|
| Apoptosis | 2 | 2012 | 354 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2015 | 257 | 0.110 |
Why?
|
| Vasculitis | 1 | 2013 | 23 | 0.110 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2003 | 3 | 0.110 |
Why?
|
| Diamide | 2 | 2003 | 3 | 0.110 |
Why?
|
| Lipoproteins | 1 | 2013 | 84 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 24 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2012 | 24 | 0.100 |
Why?
|
| Thymus Gland | 1 | 2012 | 16 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 259 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2012 | 57 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 247 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 121 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2012 | 292 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 835 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 100 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2012 | 137 | 0.090 |
Why?
|
| Apolipoproteins A | 2 | 2008 | 25 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2012 | 185 | 0.090 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Protein Transport | 1 | 2010 | 74 | 0.090 |
Why?
|
| Cholesterol, VLDL | 3 | 2015 | 11 | 0.090 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2009 | 2 | 0.090 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2009 | 26 | 0.090 |
Why?
|
| Mutation | 3 | 2010 | 487 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2012 | 598 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 114 | 0.090 |
Why?
|
| Circular Dichroism | 2 | 2006 | 30 | 0.080 |
Why?
|
| beta-Cyclodextrins | 1 | 2008 | 4 | 0.080 |
Why?
|
| Time Factors | 3 | 2013 | 2146 | 0.080 |
Why?
|
| Endotoxemia | 1 | 2008 | 7 | 0.080 |
Why?
|
| Kringles | 1 | 2008 | 1 | 0.080 |
Why?
|
| Kinetics | 2 | 2006 | 209 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 61 | 0.080 |
Why?
|
| Lipid Peroxidation | 2 | 2005 | 32 | 0.080 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 29 | 0.080 |
Why?
|
| Biological Transport | 3 | 2013 | 69 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 36 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 82 | 0.070 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 81 | 0.070 |
Why?
|
| Lipoprotein Lipase | 1 | 2006 | 14 | 0.070 |
Why?
|
| Models, Biological | 1 | 2008 | 391 | 0.070 |
Why?
|
| Lipoxygenase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 36 | 0.060 |
Why?
|
| Gene Expression | 2 | 2006 | 334 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2005 | 46 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 47 | 0.060 |
Why?
|
| Rats | 2 | 2022 | 1586 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 48 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 80 | 0.060 |
Why?
|
| Peptides | 1 | 2005 | 119 | 0.060 |
Why?
|
| Echium | 2 | 2015 | 10 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 211 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 63 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 629 | 0.060 |
Why?
|
| Cholesterol, LDL | 2 | 2014 | 173 | 0.050 |
Why?
|
| Rats, Inbred SHR | 1 | 2022 | 31 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 2013 | 36 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2022 | 30 | 0.050 |
Why?
|
| Acetates | 1 | 2022 | 10 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 607 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2015 | 74 | 0.050 |
Why?
|
| Ceramides | 2 | 2012 | 10 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 118 | 0.050 |
Why?
|
| Fatty Liver | 2 | 2015 | 65 | 0.050 |
Why?
|
| Neutrophils | 2 | 2013 | 112 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 97 | 0.050 |
Why?
|
| Carbon | 1 | 2021 | 12 | 0.050 |
Why?
|
| Myocardium | 1 | 2022 | 186 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 156 | 0.050 |
Why?
|
| Cell Wall | 1 | 2019 | 6 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2019 | 8 | 0.040 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2019 | 13 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 725 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2012 | 84 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2019 | 70 | 0.040 |
Why?
|
| Endotoxins | 1 | 2019 | 37 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 164 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2010 | 251 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 551 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 12 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 24 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 19 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 21 | 0.030 |
Why?
|
| gamma-Linolenic Acid | 1 | 2015 | 9 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 80 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 48 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 73 | 0.030 |
Why?
|
| Proteome | 1 | 2015 | 39 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 283 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 103 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 355 | 0.030 |
Why?
|
| Particle Size | 1 | 2013 | 46 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 323 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 40 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 261 | 0.030 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2013 | 38 | 0.030 |
Why?
|
| Bile | 1 | 2013 | 7 | 0.030 |
Why?
|
| Feces | 1 | 2013 | 34 | 0.030 |
Why?
|
| Foam Cells | 1 | 2013 | 13 | 0.030 |
Why?
|
| Animal Feed | 1 | 2013 | 16 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 46 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 230 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2003 | 4 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 177 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2012 | 6 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2012 | 7 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 727 | 0.030 |
Why?
|
| Cell Line | 1 | 2013 | 434 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2012 | 9 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 208 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 94 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 124 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 142 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2003 | 508 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 76 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Apolipoprotein B-100 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 52 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 54 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 312 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 30 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 39 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2008 | 74 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 75 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 564 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 468 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 122 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 290 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 103 | 0.020 |
Why?
|
| Lung | 1 | 2008 | 255 | 0.020 |
Why?
|
| Protein Binding | 1 | 2006 | 201 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 216 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 2003 | 6 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2003 | 13 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 22 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2002 | 15 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 122 | 0.010 |
Why?
|